Heparin Market Growth: Market Expansion and Strategies
Heparin Market Size
was estimated at USD 7.5 billion in 2022 and is poised to reach at 9.20 billion
in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of
2.6% for the forecast period of 2023-2030.
The Heparin market is expected to witness significant growth
in the coming years. Heparin, a naturally occurring anticoagulant, is widely
used in various medical applications such as surgeries, dialysis, and treatment
of deep vein thrombosis. The increasing prevalence of cardiovascular diseases
and the growing aging population are major factors driving the demand for
heparin.
One of the key drivers for the growth of the heparin market
is the rising incidence of venous thromboembolism (VTE) worldwide. VTE includes
conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE), which
can be life-threatening if not treated promptly. Heparin plays a crucial role
in preventing and treating these conditions, thereby fueling its demand.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2975
Moreover, advancements in healthcare infrastructure and
increasing healthcare expenditure are also contributing to market growth. The
availability of improved diagnostic techniques and surgical procedures has led
to a higher demand for heparin during surgeries and other medical
interventions.
KEY MARKET SEGMENTS
By Type
·
Low Molecular Weight Heparin
·
Ultra-low Molecular Weight Heparin
·
Unfractionated Heparin
By Route of Administration
·
Intravenous
·
Subcutaneous
By Application
·
Venous Thromboembolism
·
Atrial Fibrillation
·
Renal Impairment
·
Coronary Artery Disease
·
Others
By End-use
·
Outpatient
·
Inpatient
By Source
·
Porcine
·
Bovine
·
Others
Major Players Listed in the Report are as Follows:
Pfizer
Inc., Techdow USA Inc., Hepalink Group,LEO Pharma A/S, Dr. Reddy’s Laboratories
Ltd., GlaxoSmithKline plc, Sanofi, Aspen Holdings, Fresenius SE & Co. KGaA,
B. Braun Medical, Inc., Sandoz (Novartis AG), Hebei Changshan Biochemical Pharmaceutical
Co, Ltd, and others.
Other
Report
Autoimmune
Disease Testing Market Growth
About US:
SNS Insider has been a leader in data and analytics globally
with its authentic consumer and market insights. The trust of our clients and
business partners has always been at the center of who we are as a company. We
are a business that leads the industry in innovation, and to support the
success of our clients, our highly skilled engineers, consultants, and data
scientists have consistently pushed the limits of the industry with innovative
methodology and measuring technologies.
We assist our clients to anticipate industrial, economic,
and consumer trends to drive disruptive change by fusing global experience with
local information from experts throughout the world. We bring context to
strategic and tactical data by bridging approaches based on data science and
field research, assisting you in addressing your most pressing problems and
spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Comments
Post a Comment